These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 35317923)

  • 1. Incremental net benefit of whole genome sequencing for newborns and children with suspected genetic disorders: Systematic review and meta-analysis of cost-effectiveness evidence.
    Nurchis MC; Riccardi MT; Radio FC; Chillemi G; Bertini ES; Tartaglia M; Cicchetti A; Dallapiccola B; Damiani G
    Health Policy; 2022 Apr; 126(4):337-345. PubMed ID: 35317923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bayesian cost-effectiveness analysis of Whole genome sequencing versus Whole exome sequencing in a pediatric population with suspected genetic disorders.
    Nurchis MC; Radio FC; Salmasi L; Heidar Alizadeh A; Raspolini GM; Altamura G; Tartaglia M; Dallapiccola B; Damiani G
    Eur J Health Econ; 2024 Aug; 25(6):999-1011. PubMed ID: 37975990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness of Whole-Genome vs Whole-Exome Sequencing Among Children With Suspected Genetic Disorders.
    Nurchis MC; Radio FC; Salmasi L; Heidar Alizadeh A; Raspolini GM; Altamura G; Tartaglia M; Dallapiccola B; Pizzo E; Gianino MM; Damiani G
    JAMA Netw Open; 2024 Jan; 7(1):e2353514. PubMed ID: 38277144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incremental yield of whole-genome sequencing over chromosomal microarray analysis and exome sequencing for congenital anomalies in prenatal period and infancy: systematic review and meta-analysis.
    Shreeve N; Sproule C; Choy KW; Dong Z; Gajewska-Knapik K; Kilby MD; Mone F
    Ultrasound Obstet Gynecol; 2024 Jan; 63(1):15-23. PubMed ID: 37725747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole Genome Sequencing in the Evaluation of Fetal Structural Anomalies: A Parallel Test with Chromosomal Microarray Plus Whole Exome Sequencing.
    Zhou J; Yang Z; Sun J; Liu L; Zhou X; Liu F; Xing Y; Cui S; Xiong S; Liu X; Yang Y; Wei X; Zou G; Wang Z; Wei X; Wang Y; Zhang Y; Yan S; Wu F; Zeng F; Wang J; Duan T; Peng Z; Sun L
    Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33800913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole genome sequencing diagnostic yield for paediatric patients with suspected genetic disorders: systematic review, meta-analysis, and GRADE assessment.
    Nurchis MC; Altamura G; Riccardi MT; Radio FC; Chillemi G; Bertini ES; Garlasco J; Tartaglia M; Dallapiccola B; Damiani G
    Arch Public Health; 2023 May; 81(1):93. PubMed ID: 37231492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-genome sequencing offers additional but limited clinical utility compared with reanalysis of whole-exome sequencing.
    Alfares A; Aloraini T; Subaie LA; Alissa A; Qudsi AA; Alahmad A; Mutairi FA; Alswaid A; Alothaim A; Eyaid W; Albalwi M; Alturki S; Alfadhel M
    Genet Med; 2018 Nov; 20(11):1328-1333. PubMed ID: 29565419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are whole-exome and whole-genome sequencing approaches cost-effective? A systematic review of the literature.
    Schwarze K; Buchanan J; Taylor JC; Wordsworth S
    Genet Med; 2018 Oct; 20(10):1122-1130. PubMed ID: 29446766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of the diagnostic and clinical utility of genome and exome sequencing and chromosomal microarray in children with suspected genetic diseases.
    Clark MM; Stark Z; Farnaes L; Tan TY; White SM; Dimmock D; Kingsmore SF
    NPJ Genom Med; 2018; 3():16. PubMed ID: 30002876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis.
    Ewans LJ; Minoche AE; Schofield D; Shrestha R; Puttick C; Zhu Y; Drew A; Gayevskiy V; Elakis G; Walsh C; Adès LC; Colley A; Ellaway C; Evans CA; Freckmann ML; Goodwin L; Hackett A; Kamien B; Kirk EP; Lipke M; Mowat D; Palmer E; Rajagopalan S; Ronan A; Sachdev R; Stevenson W; Turner A; Wilson M; Worgan L; Morel-Kopp MC; Field M; Buckley MF; Cowley MJ; Dinger ME; Roscioli T
    Eur J Hum Genet; 2022 Oct; 30(10):1121-1131. PubMed ID: 35970915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organizational Aspects of the Implementation and Use of Whole Genome Sequencing and Whole Exome Sequencing in the Pediatric Population in Italy: Results of a Survey.
    Nurchis MC; Raspolini GM; Heidar Alizadeh A; Altamura G; Radio FC; Tartaglia M; Dallapiccola B; Damiani G
    J Pers Med; 2023 May; 13(6):. PubMed ID: 37373888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using molecular testing and whole-genome sequencing for tuberculosis diagnosis in a low-burden setting: a cost-effectiveness analysis using transmission-dynamic modelling.
    Mugwagwa T; Abubakar I; White PJ
    Thorax; 2021 Mar; 76(3):281-291. PubMed ID: 33542086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using the Sankey diagram to visualize article features on the topics of whole-exome sequencing (WES) and whole-genome sequencing (WGS) since 2012: Bibliometric analysis.
    Li MJ; Chien TW; Liao KW; Lai FJ
    Medicine (Baltimore); 2022 Sep; 101(38):e30682. PubMed ID: 36197161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive prenatal diagnostics: Exome versus genome sequencing.
    Miceikaite I; Fagerberg C; Brasch-Andersen C; Torring PM; Kristiansen BS; Hao Q; Sperling L; Ibsen MH; Löser K; Bendsen EA; Ousager LB; Larsen MJ
    Prenat Diagn; 2023 Aug; 43(9):1132-1141. PubMed ID: 37355983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A microcosting and cost-consequence analysis of clinical genomic testing strategies in autism spectrum disorder.
    Tsiplova K; Zur RM; Marshall CR; Stavropoulos DJ; Pereira SL; Merico D; Young EJ; Sung WWL; Scherer SW; Ungar WJ
    Genet Med; 2017 Nov; 19(11):1268-1275. PubMed ID: 28471434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Yield and Economic Implications of Whole-Exome Sequencing for ASD Diagnosis in Israel.
    Tal-Ben Ishay R; Shil A; Solomon S; Sadigurschi N; Abu-Kaf H; Meiri G; Flusser H; Michaelovski A; Dinstein I; Golan H; Davidovitch N; Menashe I
    Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole exome sequencing in neurogenetic odysseys: An effective, cost- and time-saving diagnostic approach.
    Córdoba M; Rodriguez-Quiroga SA; Vega PA; Salinas V; Perez-Maturo J; Amartino H; Vásquez-Dusefante C; Medina N; González-Morón D; Kauffman MA
    PLoS One; 2018; 13(2):e0191228. PubMed ID: 29389947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.
    Mackley MP; Fletcher B; Parker M; Watkins H; Ormondroyd E
    Genet Med; 2017 Mar; 19(3):283-293. PubMed ID: 27584911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of whole genome sequencing in neurodevelopmental disorders.
    Runheim H; Pettersson M; Hammarsjö A; Nordgren A; Henriksson M; Lindstrand A; Levin LÅ; Soller MJ
    Sci Rep; 2023 Apr; 13(1):6904. PubMed ID: 37106068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions.
    Tan TY; Dillon OJ; Stark Z; Schofield D; Alam K; Shrestha R; Chong B; Phelan D; Brett GR; Creed E; Jarmolowicz A; Yap P; Walsh M; Downie L; Amor DJ; Savarirayan R; McGillivray G; Yeung A; Peters H; Robertson SJ; Robinson AJ; Macciocca I; Sadedin S; Bell K; Oshlack A; Georgeson P; Thorne N; Gaff C; White SM
    JAMA Pediatr; 2017 Sep; 171(9):855-862. PubMed ID: 28759686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.